Compare SRRK & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | FSS |
|---|---|---|
| Founded | 2012 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.6B |
| IPO Year | 2018 | 1994 |
| Metric | SRRK | FSS |
|---|---|---|
| Price | $47.76 | $118.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $56.17 | ★ $131.75 |
| AVG Volume (30 Days) | ★ 1.2M | 561.6K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.46% |
| EPS Growth | N/A | ★ 14.57 |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $2,180,500,000.00 |
| Revenue This Year | N/A | $20.94 |
| Revenue Next Year | $534.24 | $6.79 |
| P/E Ratio | ★ N/A | $103.33 |
| Revenue Growth | N/A | ★ 17.14 |
| 52 Week Low | $27.07 | $101.19 |
| 52 Week High | $58.49 | $134.51 |
| Indicator | SRRK | FSS |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 50.30 |
| Support Level | $45.46 | $113.64 |
| Resistance Level | $48.23 | $122.44 |
| Average True Range (ATR) | 2.44 | 4.30 |
| MACD | -1.01 | -0.64 |
| Stochastic Oscillator | 6.24 | 25.81 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.